

See product citations (6)
QUICK LINKS
5,5′-Dihydroxylysinonorleucine (DHLNL) is a collagen reducible crosslink agent. It works by inhibiting the activity of various enzymes, including cyclooxygenase-2 (COX-2) and phosphodiesterase-4 (PDE4), and modulates the activity of various signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway and the nuclear factor-kappa B (NF-κB) pathway. 5,5′-Dihydroxylysinonorleucine may act to exhibit anti-inflammatory, anti-cancer, and neuroprotective properties.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
5,5′-Dihydroxylysinonorleucine, 500 µg | sc-207059 | 500 µg | $784.00 | |||
5,5′-Dihydroxylysinonorleucine, 1 mg | sc-207059B | 1 mg | $940.00 | |||
5,5′-Dihydroxylysinonorleucine, 2 mg | sc-207059C | 2 mg | $1200.00 | |||
5,5′-Dihydroxylysinonorleucine, 5 mg | sc-207059D | 5 mg | $2200.00 | |||
5,5′-Dihydroxylysinonorleucine, 10 mg | sc-207059E | 10 mg | $3500.00 |